ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 137 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,833,000 | +9366.4% | 372 | -90.3% | 0.02% | -83.3% |
| Q2 2016 | $125,000 | -99.9% | 3,836 | -34.1% | 0.10% | -1.0% |
| Q1 2016 | $162,755,000 | +164299.0% | 5,821 | +110.1% | 0.10% | +71.7% |
| Q4 2015 | $99,000 | -43.1% | 2,771 | -47.2% | 0.06% | -50.8% |
| Q3 2015 | $174,000 | -42.2% | 5,251 | -27.0% | 0.12% | -32.6% |
| Q2 2015 | $301,000 | +25.4% | 7,195 | -2.2% | 0.18% | +34.1% |
| Q1 2015 | $240,000 | -81.1% | 7,360 | -81.6% | 0.14% | -76.7% |
| Q4 2014 | $1,268,000 | +18.6% | 39,950 | -7.5% | 0.58% | +15.3% |
| Q3 2014 | $1,069,000 | +8.3% | 43,180 | -1.2% | 0.50% | +10.3% |
| Q2 2014 | $987,000 | +78.8% | 43,710 | +92.8% | 0.46% | +61.3% |
| Q1 2014 | $552,000 | -2.6% | 22,670 | 0.0% | 0.28% | -2.4% |
| Q4 2013 | $567,000 | -39.1% | 22,670 | -33.1% | 0.29% | -40.5% |
| Q3 2013 | $931,000 | – | 33,893 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |